Changes in Skeletal Muscle Thickness in Patients With Acute Heart Failure
Launched by TUFTS MEDICAL CENTER · Feb 1, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how heart failure can affect muscle mass in patients who are experiencing severe heart problems, specifically those in cardiogenic shock. Researchers want to see how much muscle mass patients lose during this critical time and how it relates to their recovery after getting advanced treatments like heart transplants or devices that help pump blood. By using ultrasound imaging, the study aims to provide valuable information about changes in muscle mass before and after these treatments, which could help improve patients' quality of life.
To participate in this study, you need to be over 18 years old and have a weakened heart (with a measurement called ejection fraction below 40%) along with specific signs of cardiogenic shock. This might include low blood pressure or signs of organ stress. However, if you have a history of certain muscle diseases or are on specific types of nutrition support, you may not be eligible. Participants can expect to have their muscle mass monitored during their hospital stay, which could contribute to better care for heart failure patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Over 18 years of age
- • 2. Ejection fraction \<40%
- • 3. Cardiogenic shock defined by clinical criteria (including any of: lactate \>2.5 mmol/L, systolic blood pressure \<90 mmHg, acute kidney or liver injury, or cardiac index \<2.1 on hemodynamic monitoring) plus the clinical requirement for at least one pressor, inotrope, or temporary mechanical circulatory support device (MCSD)
- Exclusion Criteria:
- • 1. History of LVAD or other durable ventricular assist device
- • 2. An identified clinical disorder associated with skeletal muscle weakness/wasting (e.g., muscular dystrophy, mitochondrial disorder, active cancer, modified Rankin score greater or equal to 4 post-stroke
- • 3. Chronic enteric and parenteral nutrition support patients
- • Intubation or prior history of heart transplantation are not exclusion criteria if the inclusion criteria are otherwise met.
About Tufts Medical Center
Tufts Medical Center is a leading academic medical institution located in Boston, Massachusetts, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a sponsor of clinical trials, Tufts Medical Center leverages its expertise in diverse medical disciplines to develop and test new therapies, enhance patient care, and contribute to the scientific community. With a focus on collaboration and rigorous methodologies, the center aims to translate research findings into practical applications that improve health outcomes for patients locally and globally. Its dedication to excellence is reflected in its partnerships with academic institutions, industry leaders, and healthcare organizations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported